Biohaven Pharmaceutical Holding Company Ltd. Stock
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.07 USD | -0.45% | -4.49% | -76.90% |
May. 31 | Biohaven Insider Bought Shares Worth $996,240, According to a Recent SEC Filing | MT |
May. 15 | Biohaven Insider Bought Shares Worth $512,877, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2020 | 63.63 | Sales 2021 | 462.51 | Capitalization | 9.03B |
---|---|---|---|---|---|
Net income 2020 | -767M | Net income 2021 | -847M | EV / Sales 2020 | 87,534,473 x |
Net Debt 2020 | 432M | Net Debt 2021 | 860M | EV / Sales 2021 | 21,377,123 x |
P/E ratio 2020 |
-6.56
x | P/E ratio 2021 |
-10.5
x | Employees | 928 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 90.13% |
1 day | -0.45% | ||
Current month | -76.90% | ||
Current year | -76.90% |
Managers | Title | Age | Since |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 22-10-02 |
Jon Blaskovich
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 17-10-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 22-10-02 |
Gastón Ortega
BRD | Director/Board Member | - | 22-10-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.97% | 0 M€ | 0.00% | - | |
0.11% | 9 M€ | -.--% | - | |
0.06% | 744 M€ | +8.16% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 35.07 | -0.45% | 1,399,398 |
24-05-30 | 35.23 | +6.21% | 1,999,508 |
24-05-29 | 33.17 | -12.57% | 7,951,604 |
24-05-28 | 37.94 | +3.32% | 2,027,687 |
24-05-24 | 36.72 | +0.58% | 1,406,616 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-76.90% | 541M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- BHVN Stock